ILA
Case 59: Immune Checkpoint Inhibitor - Nivolumab - Lung Injury / ILD and Recognizing Pre-Existing ILA/ILD Paid Members Public
Immune checkpoint inhibitor lung injury is not uncommon and needs to be recognized
Case 36: Gradually, then Suddenly. ILA to ILD Paid Members Public
Gradually, then suddenly. ILA to ILD
